(Q46774609)

English

Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

Sandra G Resnick

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

T. Scott Stroup

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jeffrey Lieberman

10

object named as

Jeffrey Lieberman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Robert A. Rosenheck

2

object named as

Robert A Rosenheck

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Jose M Canive

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Cyril De Souza

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Joseph McEvoy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sonia Davis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Richard S E Keefe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Marvin Swartz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

2 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Journal of Behavioral Health Services and Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

215-225

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

The well-being of chronic mental patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11414-007-9101-3

21 January 2018

Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11414-007-9101-3

21 January 2018

A prospective analysis of work in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS11414-007-9101-3

21 January 2018

Clinical trials in psychiatry: should protocol deviation censor patient data?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The New Hampshire study of supported employment for people with severe mental illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An empirical conceptualization of the recovery orientation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression analysis for correlated data

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients : estimates from a prospective naturalistic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Barriers to employment for people with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18246429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11414-007-9101-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246429%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46774609&oldid=2208094120"